Cosmo First Q1 FY27: Growth Builds as Capex Peaks and Deleveraging Starts

Cosmo First entered FY27 with a quarter that blended fast topline growth with early signals of a shift from heavy investment to value creation. For the quarter ended June 30, 2026, net revenue rose to ₹1,166 crore, up 46 percent year on year. EBITDA increased to ₹147 crore, up from ₹116 crore, while PAT improved 25 percent to ₹54 crore with EPS of ₹20.7 (not annualized). The numbers reflect a business still driven by films, but with specialty chemicals and rigid packaging improving meaningfully and consumer businesses scaling with planned value unlocks.

Management framed the quarter as the start of a new phase. The company has completed more than ₹1,200 crore of strategic capex over the last three years, with major capacities now commissioned and limited capex planned ahead. Net debt stood at ₹1,166 crore as of June 2026, translating to 2.3x EBITDA, down from 2.9x in June 2025. The company is targeting Net Debt to EBITDA below 2.0x within 12 to 18 months. This matters because it signals a pivot toward cash generation, utilization improvement, and ROCE uplift as new assets move closer to full output.

The quarter also showed how Cosmo First’s growth is being shaped by two forces. First, realizations rose with raw material prices, which inflated revenue growth relative to volumes. Second, operational improvements are starting to show across businesses that were earlier in investment mode. Management noted EBITDA improved on higher sales volume, improved base BOPP and BOPET margins, better performance in the USA film business, and stronger performance from the specialty chemical subsidiary and rigid packaging. At the same time, the consolidated EBITDA margin moved down to 12.6 percent from 14.5 percent, largely because revenue rose sharply with raw material linked realizations.

Q1 FY27 in numbers and what they suggest

Cosmo First’s reported growth is strong, but investors need to read through mix and margin. The company stated volume growth of 9 percent year on year, while revenue growth was 46 percent, indicating a large part of the topline jump came from price effects rather than pure volume. However, management also stated that gross margin per kg improved across base, semi-specialty and specialty categories, suggesting that the underlying product economics improved even as reported margins were diluted by the pricing cycle.

A useful way to view the quarter is to link the income statement to the balance sheet direction. Net debt stayed broadly flat at ₹1,166 crore despite a working capital increase of ₹85 crore, which management attributed to higher raw material prices after the West Asia conflict. In that context, maintaining flat net debt while delivering higher EBITDA points to the start of deleveraging driven by operating performance rather than asset sales or one-off actions.

Films remains the core, but mix and utilization are the swing factors

Cosmo Films is still the main earnings engine. In Q1 FY27, the flexible packaging films segment reported sales of ₹1,034 crore versus ₹714 crore, up 46 percent. Segment EBITDA increased 15 percent to ₹140 crore from ₹122 crore. The growth was supported by improved base BOPP and BOPET margins and better performance in the USA film business, as highlighted in management commentary.

Operationally, the film business is transitioning from capacity addition to utilization improvement. The presentation indicates current utilization around 85 percent and a target to move closer to full utilization. This utilization upside is important because Cosmo has already expanded capacity substantially. BOPP capacity rose from 196K MT per annum in March 2022 to 277K MT per annum by March 2026. BOPET moved from 10K to 30K MT, CPP from 20K to 45K MT, and coating from 22K to 30K MT over the same period. With major commissioning complete, incremental profits in the next phase depend more on ramp-up and product mix than on new capex.

Mix is the second swing factor. Cosmo has built a global positioning in specialty films and aims to keep growing specialty volumes at around 10 percent CAGR. The presentation states Cosmo is among the top four globally in BOPP specialty films, the second largest player in specialty label films, and the world’s largest supplier of thermal lamination films. Exports contribute around 50 percent of revenue across 80 plus countries, with premium markets such as the U.S. and Japan called out as higher realization regions.

In Q1 FY27, the specialty and semi-specialty mix recovered to 61 percent, up from 56 percent after the commissioning of new BOPP and CPP lines, which initially produced higher base films. Management is tracking a path back to around 70 percent mix. The quarter also saw base film margins at a five quarter high, with gross margin per kg reported at 45 in Q1 FY27. The company’s message is clear: specialty mix and utilization should lift steady-state ROCE as new capacity matures.

New product development supports this mix plan. The company highlighted launches such as synthetic paper film for high-end digital printing, PVC-free green graphic films, anti-fog transparent BOPET lidding films, and innovation in high barrier and metallized CPP, retort-grade films, and UV inkjet printable label films. The R&D platform is described as the largest flexible packaging R&D infrastructure in India, with 30 plus resources, about 0.5 percent of annual revenue invested in R&D, six active patents and eleven plus in the pipeline.

Emerging engines: chemicals and rigid packaging move from promise to contribution

The quarter’s quality improved because non-film B2B segments strengthened. Specialty chemicals delivered growth with high margins. Q1 FY27 revenue was ₹66 crore, up 34 percent, while EBITDA increased 46 percent to ₹17 crore. EBITDA margin expanded to 26 percent from 24 percent. Management described specialty chemicals as a high ROCE business with 25 percent plus ROCE and positioned it as the margin engine built on niche chemistries.

The specialty chemicals platform is organized around three verticals: coating chemicals, masterbatches, and adhesives, with capacities of 7,000 MT, 10,000 MT, and 2,800 MT respectively. The company referenced product development in coatings for automotive and electronics, oil and grease barrier coatings for paper packaging, heat-seal coatings for foil surfaces, high performance PE white masterbatches, and adhesives for wheel and nozzle applications. Importantly, the slide deck sets a clear medium-term revenue ambition of ₹400 to ₹500 crore by FY30, suggesting management sees chemicals as a scalable earnings contributor rather than a small adjunct.

Rigid packaging, under Cosmo Plastech, also showed a shift from losses toward normalization. The segment’s Q1 FY27 revenue grew 58 percent year on year and the business turned EBITDA positive. The segment EBITDA table shows Q1 FY27 EBITDA at ₹5 crore versus a loss of ₹6 crore in Q1 FY26. The company noted a one-time government incentive of ₹2.4 crore within Plastech, and stated that excluding this, normalized EBITDA would be around 7 percent. Management’s focus for FY27 is higher utilization and efficiency to lift profitability.

Cosmo Plastech’s positioning is end-to-end rigid packaging with products across plastic sheets, thermoformed cups and trays, and injection molded IML containers. The business emphasizes brand and specialty sales, with brand mix at 58 percent in Q1 FY27 and specialty mix at 54 percent, both improved versus the prior year quarter. It is also FSSC 22000 food safety certified. The presentation includes a FY30 target of ₹350 to ₹400 crore revenue with double-digit EBITDA and ROCE targets, which, if executed, would increase the share of non-film EBITDA that the company is explicitly targeting over the next three years.

Consumer bets: scaling, but still in investment mode

Cosmo First is building consumer-facing verticals alongside its industrial core. The consumer film products business, which includes window films, paint protection films and ceramic coatings, is at an early stage but scaling fast. Q1 FY27 revenue was ₹11 crore, described as a 4.5x year on year increase, with an annualized run rate of ₹45 crore. The business reported an EBITDA loss of ₹1 crore in the quarter, which the company attributed largely to marketing expenses. The presentation shows distribution expansion to 100 plus cities, 150 plus window film distributors or dealers, and 150 plus PPF distributors.

The market sizing in the presentation clarifies why management is investing. The India heat control window film market is estimated at around ₹1,000 crore per annum, with only two producers in India including Cosmo, and industry growth around 8 percent per annum. For paint protection films, the India market is estimated around ₹500 crore and growing 30 percent year on year, with penetration of 1 to 2 percent versus around 15 percent in China. The company also highlighted export opportunity in a multi-billion dollar global window film market and expects higher margins in exports, supported by India cost advantage and regulatory tailwinds linked to energy efficiency mandates.

Zigly, the petcare platform, continued to expand rapidly on revenue, with Q1 FY27 net sales of ₹18.4 crore versus ₹10.8 crore, a 70 percent increase. The company referenced a GMV annualized run rate of ₹100 crore and gross margins of 47 percent, unchanged year on year. The network reached 47 retail centers with four new openings in the quarter, and the retail mix remains services-led, with services contributing 64 percent of retail sales mix in Q1 FY27. The platform served 29,000 customers in the quarter and reported private label sales growth of around 105 percent year on year.

From an investor perspective, Zigly is still in build-out mode, reflected in higher EBITDA losses, moving from a loss of ₹10 crore in Q1 FY26 to a loss of ₹14 crore in Q1 FY27. But the company has also stated a plan to unlock value in the petcare vertical by end of FY27. That sets a milestone for investors to track, especially since the company is simultaneously trying to reduce leverage and scale multiple verticals.

The bigger picture: value creation depends on execution in three levers

Cosmo First’s presentation outlines a straightforward playbook for the next 12 to 24 months. First is utilization. Management expects incremental volumes by moving from roughly 85 percent utilization toward near full utilization. With large capex already behind, utilization gains should translate more directly into returns.

Second is mix. Specialty films remain the heart of differentiation, and the company is pushing specialty and semi-specialty mix back toward the earlier 70 percent level while maintaining a stated 10 percent CAGR specialty growth ambition. The quarter already showed mix recovery to 61 percent and improved gross margin per kg, a useful combination.

Third is deleveraging and ROCE. Net debt to EBITDA has improved to 2.3x, and management is targeting below 2.0x within 12 to 18 months. With capex described as minimal ahead and renewable power usage already around 50 percent, the company is trying to shift from building capacity to extracting cost savings and returns. The ESG section also mentions a plan to move renewable energy mix to two-thirds in 12 to 18 months, with estimated savings of ₹25 crore per annum, which can directly support margin stability.

The key risk in this transition is that the company is managing a portfolio where films are profitable and large, chemicals and rigid packaging are improving but still scaling, and consumer businesses require investment. The segment EBITDA bridge shows that consumer and petcare losses still drag consolidated margins, even as B2B businesses remain profitable. Management’s commentary recognizes this by emphasizing higher specialty films sales and improved utilization for ROCE, while also stating that B2C businesses continue to grow in line with Q1 FY27 growth trends.

Takeaways for investors

Cosmo First’s Q1 FY27 performance supports the narrative that the investment phase is ending and the value creation phase is starting, but it is not yet complete. Revenue and EBITDA growth were strong, and PAT expanded, while leverage improved and capex intensity is set to decline. The film business remains central, with a clear roadmap around specialty mix and utilization, backed by R&D and global exports.

The quarter also showed that the next leg of earnings quality may come from two sources. Specialty chemicals delivered high margins and set a FY30 scale target, and rigid packaging moved into positive EBITDA with improving brand and specialty mix. Consumer verticals are still loss-making at EBITDA, but scaling quickly, and Zigly’s planned value unlock by end of FY27 gives investors a time-bound marker.

If the company executes on utilization, specialty mix recovery, and net debt reduction, FY27 could look less like a continuation of capex-led growth and more like the start of a steadier, higher ROCE cycle. The presentation makes that the core quarterly theme: disciplined execution after a large build-out, with growth engines in place and a clear focus on returns.